ADAR3 inhibitors are a class of chemical compounds specifically designed to target and inhibit the function of Adenosine Deaminase Acting on RNA 3 (ADAR3), an enzyme that plays a key role in RNA editing, a post-transcriptional process that modifies RNA sequences by converting adenosine (A) to inosine (I) within double-stranded RNA regions. ADAR3 is a member of the ADAR family, which is involved in the regulation of gene expression and the diversification of the transcriptome. Unlike its more widely studied counterparts, ADAR1 and ADAR2, ADAR3 is predominantly expressed in the brain and is thought to have a regulatory role, modulating the activity of other ADAR enzymes rather than catalyzing RNA editing directly. ADAR3 is believed to bind to RNA substrates and inhibit editing by competing with ADAR1 and ADAR2, thereby influencing the editing landscape of RNAs involved in neural function and development. By inhibiting ADAR3, researchers can modulate the RNA editing process, providing a valuable tool to study the specific contributions of ADAR3 to RNA metabolism and neural biology.
In research, ADAR3 inhibitors are valuable for exploring the mechanisms of RNA editing and the broader implications of RNA modifications on gene expression and cellular function. By blocking ADAR3 activity, scientists can investigate how the inhibition affects RNA editing patterns, particularly in the context of neural tissue where ADAR3 is most active. This inhibition allows researchers to study the role of ADAR3 in regulating the balance of RNA editing mediated by ADAR1 and ADAR2 and to examine the downstream effects on mRNA splicing, stability, and translation. Additionally, ADAR3 inhibitors enable the investigation of the interactions between ADAR3 and other RNA-binding proteins, providing insights into the complex regulatory networks that govern RNA processing and function in the brain. Through these studies, the use of ADAR3 inhibitors enhances our understanding of the molecular mechanisms underlying RNA editing, the role of ADAR3 in neural gene expression, and the broader implications of RNA modifications in neurobiology and cellular regulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pentostatin | 53910-25-1 | sc-204177 sc-204177A | 10 mg 50 mg | $175.00 $702.00 | 5 | |
Pentostatin is an inhibitor of adenosine deaminase involved in nucleic acid metabolism, which might indirectly influence ADAR3 function. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $63.00 $110.00 $214.00 | 1 | |
Ribavirin, a nucleoside analog, may impact RNA editing processes, potentially influencing ADAR3 activity. | ||||||
2-Chloro-2′-deoxyadenosine | 4291-63-8 | sc-202399 | 10 mg | $144.00 | 1 | |
Cladribine is a nucleoside analog that targets nucleic acid metabolism and may indirectly impact ADAR3 function. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine, a DNA methyltransferase inhibitor, can alter gene expression and potentially impact pathways involving ADAR3. | ||||||
Guanabenz acetate | 23256-50-0 | sc-203590 sc-203590A sc-203590B sc-203590C sc-203590D | 100 mg 500 mg 1 g 10 g 25 g | $102.00 $468.00 $832.00 $4162.00 $7283.00 | 2 | |
Guanabenz, which can affect stress responses in cells, might indirectly impact ADAR3's role in RNA editing. | ||||||
Temozolomide | 85622-93-1 | sc-203292 sc-203292A | 25 mg 100 mg | $91.00 $255.00 | 32 | |
Temozolomide, an alkylating agent, can affect nucleic acid integrity and potentially influence ADAR3-related processes. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can modulate various biochemical pathways, potentially affecting ADAR3's function indirectly. | ||||||